| Income Statement for Wex Pharmaceuticals Inc. (WXI:CA) | | | | | | | Income | in Thousands of Dollars | | | 03/2008 | 03/2007 | 03/2006 | 03/2005 | 03/2004 | | | Operating Revenue | 1,002 | 545 | 629 | 3,990 | 731 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (727) | (355) | (807) | (681) | (566) | | Gross Operating Profit | 275 | 190 | (178) | 3,309 | 165 | | | Selling/General/Admin Expense | (3,049) | (2,546) | (4,458) | (5,218) | (3,749) | | Research & Development | (1,447) | (1,748) | (10,641) | (8,636) | (3,961) | | EBITDA | (4,222) | (4,104) | (15,277) | (10,544) | (7,545) | | Depreciation & Amortization | 262 | (91) | (453) | (490) | (175) | | EBIT | (3,960) | (4,195) | (15,730) | (11,035) | (7,720) | | Interest Income | 56 | 111 | 365 | 447 | 149 | | Other Income, Net | 1,464 | (82) | (1,159) | (518) | (170) | | Total Income Avail For Interest Expense | (2,440) | (3,994) | (20,918) | (11,105) | (7,742) | | Interest Expense | (349) | (766) | (704) | (560) | - | | Pre-Tax Income | (2,790) | (4,760) | (21,622) | (11,665) | (7,742) | | Income Taxes | (10) | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (2,799) | (4,760) | (21,622) | (11,665) | (7,742) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (2,799) | (4,760) | (21,622) | (11,665) | (7,742) | | | Normalized Income | (2,799) | (4,933) | (17,229) | (11,665) | (7,742) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | 172 | (4,394) | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (2,799) | (4,760) | (21,622) | (11,665) | (7,742) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 03/2008 | 03/2007 | 03/2006 | 03/2005 | 03/2004 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -0.05 | -0.13 | -0.62 | -0.35 | -0.30 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.05 | -0.13 | -0.62 | -0.35 | -0.30 | | | Diluted EPS from Continuing Operations | -0.05 | -0.13 | -0.62 | -0.35 | -0.30 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.05 | -0.13 | -0.62 | -0.35 | -0.30 | | | |
